Previous Article | Next Article 
Clinical Microbiology Reviews, January 1998, p. 57-80, Vol. 11, No. 1
0893-8512/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Microbiological and Clinical Aspects of Infection
Associated with Stenotrophomonas maltophilia
Miles
Denton and
Kevin G.
Kerr*
Department of Microbiology, University of
Leeds, Leeds LS2 9JT, United Kingdom
The gram-negative bacterium Stenotrophomonas maltophilia is increasingly recognized as an important cause of nosocomial infection. Infection occurs principally, but not exclusively, in debilitated and immunosuppressed individuals. Management of S. maltophilia-associated infection is problematic because many strains of the bacterium manifest resistance to multiple antibiotics. These difficulties are compounded by methodological problems in in vitro susceptibility testing for which there are, as yet, no formal guidelines. Despite its acknowledged importance as a nosocomial pathogen, little is known of the epidemiology of S. maltophilia, and although it is considered an environmental bacterium, its sources and reservoirs are often not readily apparent. Molecular typing systems may contribute to our knowledge of the epidemiology of S. maltophilia infection, thus allowing the development of strategies to interrupt the transmission of the bacterium in the hospital setting. Even less is known of pathogenic mechanisms and putative virulence factors involved in the natural history of S. maltophilia infection and this, coupled with difficulties in distinguishing colonization from true infection, has fostered the view that the bacterium is essentially nonpathogenic. This article aims to review the current taxonomic status of S. maltophilia, and it discusses the laboratory identification of the bacterium. The epidemiology of the organism is considered with particular reference to nosocomial outbreaks, several of which have been investigated by molecular typing techniques. Risk factors for acquisition of the bacterium are also reviewed, and the ever-expanding spectrum of clinical syndromes associated with S. maltophilia is surveyed. Antimicrobial resistance mechanisms, pitfalls in in vitro susceptibility testing, and therapy of S. maltophilia infections are also discussed.
*
Corresponding author. Mailing address: Department of
Microbiology, University of Leeds, Leeds, West Yorkshire LS2 9JT,
United Kingdom. Phone: 44 113 233 5617. Fax: 44 113 233 5649. E-mail: mickgk{at}leeds.ac.uk.
Clinical Microbiology Reviews, January 1998, p. 57-80, Vol. 11, No. 1
0893-8512/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Yang, T.-C., Huang, Y.-W., Hu, R.-M., Huang, S.-C., Lin, Y.-T.
(2009). AmpDI Is Involved in Expression of the Chromosomal L1 and L2 {beta}-Lactamases of Stenotrophomonas maltophilia. Antimicrob. Agents Chemother.
53: 2902-2907
[Abstract]
[Full Text]
-
Das, T., Deshmukh, H. S., Mathai, A., Reddy, A. K.
(2009). Stenotrophomonas maltophilia endogenous endophthalmitis: clinical presentation, sensitivity spectrum and management. J Med Microbiol
58: 837-838
[Abstract]
[Full Text]
-
Kaiser, S., Biehler, K., Jonas, D.
(2009). A Stenotrophomonas maltophilia Multilocus Sequence Typing Scheme for Inferring Population Structure. J. Bacteriol.
191: 2934-2943
[Abstract]
[Full Text]
-
Hu, R.-M., Chiang, K.-H., Chang, Y.-C., Yang, T.-C.
(2009). Characterization of the charge variants of L2 {beta}-lactamase in Stenotrophomonas maltophilia. J Med Microbiol
58: 318-321
[Abstract]
[Full Text]
-
Garcia, P., Monjardin, C., Martin, R., Madera, C., Soberon, N., Garcia, E., Meana, A., Suarez, J. E.
(2008). Isolation of New Stenotrophomonas Bacteriophages and Genomic Characterization of Temperate Phage S1. Appl. Environ. Microbiol.
74: 7552-7560
[Abstract]
[Full Text]
-
Nakajima, Y., Ito, K., Toshima, T., Egawa, T., Zheng, H., Oyama, H., Wu, Y.-F., Takahashi, E., Kyono, K., Yoshimoto, T.
(2008). Dipeptidyl Aminopeptidase IV from Stenotrophomonas maltophilia Exhibits Activity against a Substrate Containing a 4-Hydroxyproline Residue. J. Bacteriol.
190: 7819-7829
[Abstract]
[Full Text]
-
Foster, N. F., Harnett, G. B., Riley, T. V., Chang, B. J.
(2008). Cross-Reaction of Stenotrophomonas and Xanthomonas Species in a 23S rRNA Gene-Directed PCR for Detection of S. maltophilia. J. Clin. Microbiol.
46: 4111-4113
[Full Text]
-
Falagas, M. E., Valkimadi, P.-E., Huang, Y.-T., Matthaiou, D. K., Hsueh, P.-R.
(2008). Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review. J Antimicrob Chemother
62: 889-894
[Abstract]
[Full Text]
-
Okazaki, A., Avison, M. B.
(2008). Induction of L1 and L2 {beta}-Lactamase Production in Stenotrophomonas maltophilia Is Dependent on an AmpR-Type Regulator. Antimicrob. Agents Chemother.
52: 1525-1528
[Abstract]
[Full Text]
-
Huang, T.-P., Wong, A. C. L.
(2007). A Cyclic AMP Receptor Protein-Regulated Cell-Cell Communication System Mediates Expression of a FecA Homologue in Stenotrophomonas maltophilia. Appl. Environ. Microbiol.
73: 5034-5040
[Abstract]
[Full Text]
-
Fouhy, Y., Scanlon, K., Schouest, K., Spillane, C., Crossman, L., Avison, M. B., Ryan, R. P., Dow, J. M.
(2007). Diffusible Signal Factor-Dependent Cell-Cell Signaling and Virulence in the Nosocomial Pathogen Stenotrophomonas maltophilia. J. Bacteriol.
189: 4964-4968
[Abstract]
[Full Text]
-
Waters, V. J., Gomez, M. I., Soong, G., Amin, S., Ernst, R. K., Prince, A.
(2007). Immunostimulatory Properties of the Emerging Pathogen Stenotrophomonas maltophilia. Infect. Immun.
75: 1698-1703
[Abstract]
[Full Text]
-
LaSala, P. R., Segal, J., Han, F. S., Tarrand, J. J., Han, X. Y.
(2007). First Reported Infections Caused by Three Newly Described Genera in the Family Xanthomonadaceae. J. Clin. Microbiol.
45: 641-644
[Abstract]
[Full Text]
-
Anderson, S. W., Stapp, J. R., Burns, J. L., Qin, X.
(2007). Characterization of Small-Colony-Variant Stenotrophomonas maltophilia Isolated from the Sputum Specimens of Five Patients with Cystic Fibrosis. J. Clin. Microbiol.
45: 529-535
[Abstract]
[Full Text]
-
Okazaki, A., Avison, M. B.
(2007). Aph(3')-IIc, an Aminoglycoside Resistance Determinant from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother.
51: 359-360
[Abstract]
[Full Text]
-
Qin, X., Razia, Y., Johnson, J. R., Stapp, J. R., Boster, D. R., Tsosie, T., Smith, D. L., Braden, C. R., Gay, K., Angulo, F. J., Tarr, P. I.
(2006). Ciprofloxacin-resistant gram-negative bacilli in the fecal microflora of children.. Antimicrob. Agents Chemother.
50: 3325-3329
[Abstract]
[Full Text]
-
Piccini, C., Conde, D., Alonso, C., Sommaruga, R., Pernthaler, J.
(2006). Blooms of single bacterial species in a coastal lagoon of the southwestern atlantic ocean.. Appl. Environ. Microbiol.
72: 6560-6568
[Abstract]
[Full Text]
-
Gould, V. C., Avison, M. B.
(2006). SmeDEF-mediated antimicrobial drug resistance in Stenotrophomonas maltophilia clinical isolates having defined phylogenetic relationships. J Antimicrob Chemother
57: 1070-1076
[Abstract]
[Full Text]
-
Fenollar, F., Roux, V., Stein, A., Drancourt, M., Raoult, D.
(2006). Analysis of 525 Samples To Determine the Usefulness of PCR Amplification and Sequencing of the 16S rRNA Gene for Diagnosis of Bone and Joint Infections.. J. Clin. Microbiol.
44: 1018-1028
[Abstract]
[Full Text]
-
Gould, V. C., Okazaki, A., Avison, M. B.
(2006). {beta}-Lactam resistance and {beta}-lactamase expression in clinical Stenotrophomonas maltophilia isolates having defined phylogenetic relationships. J Antimicrob Chemother
57: 199-203
[Abstract]
[Full Text]
-
Furushita, M., Okamoto, A., Maeda, T., Ohta, M., Shiba, T.
(2005). Isolation of Multidrug-Resistant Stenotrophomonas maltophilia from Cultured Yellowtail (Seriola quinqueradiata) from a Marine Fish Farm. Appl. Environ. Microbiol.
71: 5598-5600
[Abstract]
[Full Text]
-
Navarro-Martinez, M. D., Navarro-Peran, E., Cabezas-Herrera, J., Ruiz-Gomez, J., Garcia-Canovas, F., Rodriguez-Lopez, J. N.
(2005). Antifolate Activity of Epigallocatechin Gallate against Stenotrophomonas maltophilia. Antimicrob. Agents Chemother.
49: 2914-2920
[Abstract]
[Full Text]
-
Coenye, T., Spilker, T., Reik, R., Vandamme, P., LiPuma, J. J.
(2005). Use of PCR Analyses To Define the Distribution of Ralstonia Species Recovered from Patients with Cystic Fibrosis. J. Clin. Microbiol.
43: 3463-3466
[Abstract]
[Full Text]
-
Chang, H.-C., Chen, C.-R., Lin, J.-W., Shen, G.-H., Chang, K.-M., Tseng, Y.-H., Weng, S.-F.
(2005). Isolation and Characterization of Novel Giant Stenotrophomonas maltophilia Phage {phi}SMA5. Appl. Environ. Microbiol.
71: 1387-1393
[Abstract]
[Full Text]
-
Daxboeck, F., Stadler, M., Assadian, O., Marko, E., Hirschl, A. M, Koller, W.
(2005). Characterization of clinically isolated Ralstonia mannitolilytica strains using random amplification of polymorphic DNA (RAPD) typing and antimicrobial sensitivity, and comparison of the classification efficacy of phenotypic and genotypic assays. J Med Microbiol
54: 55-61
[Abstract]
[Full Text]
-
Goss, C H, Mayer-Hamblett, N, Aitken, M L, Rubenfeld, G D, Ramsey, B W
(2004). Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis. Thorax
59: 955-959
[Abstract]
[Full Text]
-
Gould, V. C., Okazaki, A., Howe, R. A., Avison, M. B.
(2004). Analysis of sequence variation among smeDEF multi drug efflux pump genes and flanking DNA from defined 16S rRNA subgroups of clinical Stenotrophomonas maltophilia isolates. J Antimicrob Chemother
54: 348-353
[Abstract]
[Full Text]
-
Coenye, T., Vanlaere, E., Falsen, E., Vandamme, P.
(2004). Stenotrophomonas africana Drancourt et al. 1997 is a later synonym of Stenotrophomonas maltophilia (Hugh 1981) Palleroni and Bradbury 1993. Int. J. Syst. Evol. Microbiol.
54: 1235-1237
[Abstract]
[Full Text]
-
Ba, B. B., Feghali, H., Arpin, C., Saux, M.-C., Quentin, C.
(2004). Activities of Ciprofloxacin and Moxifloxacin against Stenotrophomonas maltophilia and Emergence of Resistant Mutants in an In Vitro Pharmacokinetic-Pharmacodynamic Model. Antimicrob. Agents Chemother.
48: 946-953
[Abstract]
[Full Text]
-
Alonso, A., Morales, G., Escalante, R., Campanario, E., Sastre, L., Martinez, J. L.
(2004). Overexpression of the multidrug efflux pump SmeDEF impairs Stenotrophomonas maltophilia physiology. J Antimicrob Chemother
53: 432-434
[Abstract]
[Full Text]
-
Barbolla, R., Catalano, M., Orman, B. E., Famiglietti, A., Vay, C., Smayevsky, J., Centron, D., Pineiro, S. A.
(2004). Class 1 Integrons Increase Trimethoprim-Sulfamethoxazole MICs against Epidemiologically Unrelated Stenotrophomonas maltophilia Isolates. Antimicrob. Agents Chemother.
48: 666-669
[Abstract]
[Full Text]
-
Valdezate, S., Vindel, A., Martin-Davila, P., Del Saz, B. S., Baquero, F., Canton, R.
(2004). High Genetic Diversity among Stenotrophomonas maltophilia Strains Despite Their Originating at a Single Hospital. J. Clin. Microbiol.
42: 693-699
[Abstract]
[Full Text]
-
Di Bonaventura, G., Spedicato, I., D'Antonio, D., Robuffo, I., Piccolomini, R.
(2004). Biofilm Formation by Stenotrophomonas maltophilia: Modulation by Quinolones, Trimethoprim-Sulfamethoxazole, and Ceftazidime. Antimicrob. Agents Chemother.
48: 151-160
[Abstract]
[Full Text]
-
Li, X.-Z., Zhang, L., McKay, G. A., Poole, K.
(2003). Role of the acetyltransferase AAC(6')-Iz modifying enzyme in aminoglycoside resistance in Stenotrophomonas maltophilia. J Antimicrob Chemother
51: 803-811
[Abstract]
[Full Text]
-
Sanchez, P., Alonso, A., Martinez, J. L.
(2002). Cloning and Characterization of SmeT, a Repressor of the Stenotrophomonas maltophilia Multidrug Efflux Pump SmeDEF. Antimicrob. Agents Chemother.
46: 3386-3393
[Abstract]
[Full Text]
-
Betriu, C., Rodriguez-Avial, I., Sanchez, B. A., Gomez, M., Picazo, J. J.
(2002). Comparative in vitro activities of tigecycline (GAR-936) and other antimicrobial agents against Stenotrophomonas maltophilia. J Antimicrob Chemother
50: 758-759
[Full Text]
-
Goss, C. H., Otto, K., Aitken, M. L., Rubenfeld, G. D.
(2002). Detecting Stenotrophomonas maltophilia Does Not Reduce Survival of Patients with Cystic Fibrosis. Am. J. Respir. Crit. Care Med.
166: 356-361
[Abstract]
[Full Text]
-
Simm, A. M., Higgins, C. S., Carenbauer, A. L., Crowder, M. W., Bateson, J. H., Bennett, P. M., Clarke, A. R., Halford, S. E., Walsh, T. R.
(2002). Characterization of Monomeric L1 Metallo-beta -lactamase and the Role of the N-terminal Extension in Negative Cooperativity and Antibiotic Hydrolysis. J. Biol. Chem.
277: 24744-24752
[Abstract]
[Full Text]
-
Windhorst, S., Frank, E., Georgieva, D. N., Genov, N., Buck, F., Borowski, P., Weber, W.
(2002). The Major Extracellular Protease of the Nosocomial Pathogen Stenotrophomonas maltophilia. CHARACTERIZATION OF THE PROTEIN AND MOLECULAR CLONING OF THE GENE. J. Biol. Chem.
277: 11042-11049
[Abstract]
[Full Text]
-
Valdezate, S., Vindel, A., Echeita, A., Baquero, F., Canto, R.
(2002). Topoisomerase II and IV Quinolone Resistance-Determining Regions in Stenotrophomonas maltophilia Clinical Isolates with Different Levels of Quinolone Susceptibility. Antimicrob. Agents Chemother.
46: 665-671
[Abstract]
[Full Text]
-
Li, X.-Z., Zhang, L., Poole, K.
(2002). SmeC, an Outer Membrane Multidrug Efflux Protein of Stenotrophomonas maltophilia. Antimicrob. Agents Chemother.
46: 333-343
[Abstract]
[Full Text]
-
Brechtel, E., Huwig, A., Giffhorn, F.
(2002). L-Glucitol Catabolism in Stenotrophomonas maltophilia Ac. Appl. Environ. Microbiol.
68: 582-587
[Abstract]
[Full Text]
-
Avison, M. B., Higgins, C. S., Ford, P. J., von Heldreich, C. J., Walsh, T. R., Bennett, P. M.
(2002). Differential regulation of L1 and L2 {beta}-lactamase expression in Stenotrophomonas maltophilia. J Antimicrob Chemother
49: 387-389
[Abstract]
[Full Text]
-
Khan, I. A., Mehta, N. J.
(2002). Stenotrophomonas maltophilia Endocarditis: A Systematic Review. ANGIOLOGY
53: 49-55
[Abstract]
-
Zhang, L., Li, X.-Z., Poole, K.
(2001). SmeDEF Multidrug Efflux Pump Contributes to Intrinsic Multidrug Resistance in Stenotrophomonas maltophilia. Antimicrob. Agents Chemother.
45: 3497-3503
[Abstract]
[Full Text]
-
Dancer, S. J.
(2001). The problem with cephalosporins. J Antimicrob Chemother
48: 463-478
[Abstract]
[Full Text]
-
Coenye, T., Vandamme, P., Govan, J. R. W., LiPuma, J. J.
(2001). Taxonomy and Identification of the Burkholderia cepacia Complex. J. Clin. Microbiol.
39: 3427-3436
[Full Text]
-
Betriu, C., Sanchez, A., Palau, M. L., Gomez, M., Picazo, J. J.
(2001). Antibiotic resistance surveillance of Stenotrophomonas maltophilia, 1993-1999. J Antimicrob Chemother
48: 152-154
[Full Text]
-
Cohn, M. L., Waites, K. B.
(2001). Antimicrobial Activities of Gatifloxacin against Nosocomial Isolates of Stenotrophomonas maltophilia Measured by MIC and Time-Kill Studies. Antimicrob. Agents Chemother.
45: 2126-2128
[Abstract]
[Full Text]
-
Alonso, A., Martinez, J. L.
(2001). Expression of Multidrug Efflux Pump SmeDEF by Clinical Isolates of Stenotrophomonas maltophilia. Antimicrob. Agents Chemother.
45: 1879-1881
[Abstract]
[Full Text]
-
Valdezate, S., Vindel, A., Loza, E., Baquero, F., Cantón, R.
(2001). Antimicrobial Susceptibilities of Unique Stenotrophomonas maltophilia Clinical Strains. Antimicrob. Agents Chemother.
45: 1581-1584
[Abstract]
[Full Text]
-
Avison, M. B., von Heldreich, C. J., Higgins, C. S., Bennett, P. M., Walsh, T. R.
(2000). A TEM-2 {beta}-lactamase encoded on an active Tn1-like transposon in the genome of a clinical isolate of Stenotrophomonas maltophilia. J Antimicrob Chemother
46: 879-884
[Abstract]
[Full Text]
-
Alonso, A., Martínez, J. L.
(2000). Cloning and Characterization of SmeDEF, a Novel Multidrug Efflux Pump from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother.
44: 3079-3086
[Abstract]
[Full Text]
-
Bellido, J. L. M., Hernandez, F. J. S., Zufiaurre, M. N. G., Garcia-Rodriguez, J. A.
(2000). In vitro activity of newer fluoroquinolones against Stenotrophomonas maltophilia. J Antimicrob Chemother
46: 334-335
[Full Text]
-
Alonso, A., Sanchez, P., Martínez, J. L.
(2000). Stenotrophomonas maltophilia D457R Contains a Cluster of Genes from Gram-Positive Bacteria Involved in Antibiotic and Heavy Metal Resistance. Antimicrob. Agents Chemother.
44: 1778-1782
[Abstract]
[Full Text]
-
Schmitz, F.-J., Sadurski, R., Verhoef, J., Milatovic, D., Fluit, A. C.
(2000). Typing of 154 clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and determination of the in vitro susceptibilities of these strains to 28 antibiotics. J Antimicrob Chemother
45: 921-923
[Full Text]
-
Weiss, K., Restieri, C., De Carolis, E., Laverdiere, M., Guay, H.
(2000). Comparative activity of new quinolones against 326 clinical isolates of Stenotrophomonas maltophilia. J Antimicrob Chemother
45: 363-365
[Abstract]
[Full Text]
-
Bonfiglio, G., Cascone, C., Azzarelli, C., Cafiso, V., Marchetti, F., Stefani, S.
(2000). Levofloxacin in vitro activity and time-kill evaluation of Stenotrophomonas maltophilia clinical isolates. J Antimicrob Chemother
45: 115-117
[Abstract]
[Full Text]
-
Lambert, T., Ploy, M.-C., Denis, F., Courvalin, P.
(1999). Characterization of the Chromosomal aac(6')-Iz Gene of Stenotrophomonas maltophilia. Antimicrob. Agents Chemother.
43: 2366-2371
[Abstract]
[Full Text]
-
Friedrich, U., Naismith, M. M., Altendorf, K., Lipski, A.
(1999). Community Analysis of Biofilters Using Fluorescence In Situ Hybridization Including a New Probe for the Xanthomonas Branch of the Class Proteobacteria. Appl. Environ. Microbiol.
65: 3547-3554
[Abstract]
[Full Text]